Literature DB >> 25444479

Oncological and functional results after the surgical treatment of parotid cancer.

E-J Chung1, S-H Lee1, S-H Baek1, K-H Kwon1, Y-J Chang2, Y-S Rho3.   

Abstract

The objective of this study was to analyze the oncological and functional outcomes after the surgical treatment of parotid cancer. We reviewed 80 primary parotid carcinomas retrospectively. A superficial parotidectomy was performed in 10 patients; 27 patients underwent total parotidectomy and 43 patients underwent radical parotidectomy. A facial-facial nerve anastomosis was chosen for the facial nerve reconstruction in eight patients, while an interpositional graft was selected in 24 patients. The overall N-positive rate of pathology was 21.3%. The rate of occult metastasis was 8.1%. High-grade carcinoma and lymphovascular emboli were independent factors for nodal metastasis. The 5-year disease-free survival and overall survival rates were 79.7% and 78.8%, respectively. Preoperative facial nerve palsy and extraparenchymal invasion were the independent factors associated with poor disease-free survival. Of the 41 patients in the facial nerve preservation group, 13 (31.7%) had transient facial nerve paresis. In the facial nerve sacrifice group of 39 cases, (sub)total recovery (House-Brackmann grade I/II) occurred in 14 (35.9%), partial recovery (House-Brackmann grade III/IV) in 13 (33.3%), and no recovery (House-Brackmann grade V) in 12 (30.8%). Facial nerve palsy upon presentation and extraparenchymal invasion indicate a grave prognosis. Facial nerve function after proper reconstruction is tolerable.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  facial paralysis; parotid cancer; prognosis; surgery

Mesh:

Year:  2014        PMID: 25444479     DOI: 10.1016/j.ijom.2014.06.020

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  1 in total

1.  Clinical Outcome of Parotidectomy with Reconstruction: Experience of a Regional Head and Neck Cancer Unit.

Authors:  Eyituoyo Okoturo; Anslem Osasuyi
Journal:  Niger J Surg       Date:  2016 Jan-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.